Recursion Pharmaceuticals struggles with validation of REC-994 and competition in oncology. Read why RXRX stock is a hold ...
A new study argues that data centers could be ideal demand-response participants because they have the potential to be ...
Powercell Sweden (ST:PCELL) reported its Q4 2024 earnings with notable achievements, including a 30% quarterly growth and an 8% increase for the full year despite a challenging market environment.
Intelligent power management company Eaton (NYSE:ETN) is helping address the shortage of transformers and record demand for its solutions across data center, utility, large commercial and industrial ...
Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results